The 38th study group was formed in the past week exploring the history, philosophy, and ethics of clinical microbiology and infectious diseases to provide perspective on current and future challenges. Study group membership is free and open to all ESCMID members. Learn more about ESGHAMP and join today!

Science & Research

The ESCMID Mentorship Programme call opens on 17 August, but you can start connecting with your potential mentor now! The programme pairs early-career professionals with experienced colleagues who offer guidance, support, and real-world insights across their career journey. Browse the mentor profiles now and get ready to apply.

Education

The IMPACT-ICU course aims to provide an up-to-date, evidence-based educational forum for clinicians and researchers dedicated to optimising infection outcomes in critically ill patients and managing the ICU setting.

This course focuses on the diagnosis, management, and prevention of implant-associated infections, with a special emphasis on prosthetic joint infections and fracture-related infections. Participants will gain a multidisciplinary perspective, combining expertise from infectious diseases, microbiology, and orthopaedic surgery.

Congress & Events

Late-breaking abstracts should present new decisive, original results that were not yet known or fully available during the regular submission period. This is an opportunity to contribute timely evidence to the scientific discussions taking place at ICID 2026 in Madrid this November.

Submission deadline: 18 August 2026

Guidelines & Journals

Read this narrative review from the latest issue of CMI covering antifungal susceptibility testing across fungi. The authors aim to explain why fungal MICs can vary within and between methods, highlight clinically relevant MIC ‘blind spots’, and provide practical guidance for routine interpretation and confirmation.

ERS and the ESCMID partnered to provide scientific evidence regarding the usefulness of rapid diagnostic tests in improving the diagnosis of bacterial lower respiratory tract infections and reducing inappropriate antibiotic use as part of the VALUE-Dx Consortium. Read their statement in CMI Communications.

The Ebola virus disease outbreak in the Democratic Republic of the Congo has reached 3,553 confirmed cases and 1,558 deaths, the fastest-growing outbreak in recorded history. West Nile virus transmission has been identified in 49 areas across seven European countries, with Greece reporting 42 cases and four deaths, while the United States reports 113 cases. Chile has declared its first national Hantavirus Health Alert after 41 cases and 14 deaths from Andes virus. São Paulo state reports Brazilian spotted fever, with 18 deaths among 19 confirmed cases. Cholera in Cameroon has caused 754 cases and 25 deaths. Meanwhile, Cambodia reports a 58% surge in dengue cases, and Taiwan has recorded 10 Japanese encephalitis cases, including one death.

Screening for multi-drug resistance carriage and appropriate initial antibiotic treatment of ICU-acquired bloodstream infections

Beyond approval: Building a coordinated, adaptive evidence ecosystem for novel antibiotics